SPARC enters into licensing deal with CMS to develop and commercialise products EP News Bureau Nov 6, 2019 The initial term of the agreement shall be 20 years from the date of first commercial sale of each product in the territory and…
SPARC gets orphan drug designation for Phenobarbital from US FDA Press Trust of India Oct 7, 2019 Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of…
